Compumedics Limited Reports Strong Financial Outlook and Market Leadership
I'm PortAI, I can summarize articles.
Compumedics Limited (AU:CMP) reported a strong financial outlook with FY25 revenue of $51 million and a forecast exceeding A$70 million for FY26, alongside an EBITDA of approximately A$9 million. The company leads in sleep and neuro diagnostics in Australia and Japan, is the top supplier in China, and ranks third in TCD devices in Germany and neurological monitoring in the USA. The latest analyst rating is a Hold with a price target of A$0.50. Compumedics, established in 1987, operates globally with over 30,000 systems installed.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments